5.40
price up icon0.37%   0.02
pre-market  Vorhandelsmarkt:  5.48   0.08   +1.48%
loading

Finanzdaten der Replimune Group Inc-Aktie (REPL)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-06-30 2025-03-31 2024-12-31 2024-10-01 2024-07-01
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
13.98%
90.42
79.33 66.02 - -
Operating Income/Loss
13.98%
-90.42
-79.33 -66.02 - -
Nonoperating Income/Loss
26.75%
3.729
5.091 0.254 - -
Income/Loss From Continuing Operations Before Tax
16.78%
-86.69
-74.24 -65.77 -53.05 -53.77
Income Tax Expense/Benefit
100.00%
-
-0.107 0.575 - -
Income/Loss From Continuing Operations After Tax
17.69%
-86.69
-73.66 -66.34 -53.05 -53.77
Net Income/Loss
16.95%
-86.69
-74.13 -66.34 -53.05 -53.77
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
2,552%
91.52
3.4505 83.50 - -
Diluted Average Shares
2,552%
91.52
3.4505 83.50 - -
Basic Earnings Per Share
15.85%
-0.95
-0.82 -0.79 - -
Diluted Earnings Per Share
15.85%
-0.95
-0.82 -0.79 - -
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$24.87
price down icon 0.96%
$84.61
price up icon 1.09%
$23.70
price down icon 2.95%
$100.00
price down icon 1.89%
$136.10
price up icon 0.84%
biotechnology ONC
$306.05
price up icon 2.72%
Kapitalisierung:     |  Volumen (24h):